Who
Alex C. Levit
Chief Legal Officer, Corp. Sec
Company insider
Files Form 4 as: Chief Legal Officer, Corp. Sec, Context Therapeutics.
In numbers
- Trades disclosed
- 9
- Buys
- 3
- Sells
- 0
- Bought
- $32K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 22 Oct 2021
- Last trade
- 19 Feb 2026
- Last filed
- 23 Feb 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 19 Feb 2026filed 23 Feb 2026 | CNTX Context Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —270,000 at $0.00 | filing |
| 19 Feb 2026filed 23 Feb 2026 | CNTX Context Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —270,000 at $0.00 | filing |
| 6 Jun 2025filed 10 Jun 2025 | CNTX Context TherapeuticsBiotechnology | SEC FORM 4 Bought | $12K20,000 at $0.58 | filing |
| 13 Feb 2025filed 14 Feb 2025 | CNTX Context Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —349,900 at $0.00 | filing |
| 21 Mar 2024filed 22 Mar 2024 | CNTX Context Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —153,515 at $0.00 | filing |
| 13 Feb 2023filed 14 Feb 2023 | CNTX Context Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —151,505 at $0.00 | filing |
| 9 Dec 2022filed 12 Dec 2022 | CNTX Context TherapeuticsBiotechnology | SEC FORM 4 Bought | $5,1006,000 at $0.85 | filing |
| 25 Feb 2022filed 25 Feb 2022 | CNTX Context Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —107,870 at $0.00 | filing |
| 22 Oct 2021filed 25 Oct 2021 | CNTX Context TherapeuticsBiotechnology | SEC FORM 4 Bought | $15K3,000 at $5.00 | filing |
News
No headline names them, or the companies they trade most, lately.